Patent: 10,696,758
✉ Email this page to a colleague
Summary for Patent: 10,696,758
| Title: | Group 4 catalyst compounds and process for use thereof |
| Abstract: | This invention relates to metallocene compounds having a group substituted at the 3 position of at least one cyclopentadienyl ring represented by the formula —CH2—SiR′3 or —CH2—CR′3 and R′ is a C1 to C20 substituted or unsubstituted hydrocarbyl. |
| Inventor(s): | Subramaniam Kuppuswamy, Matthew W. Holtcamp, David M. Fiscus, Matthew S. Bedoya, Laughlin G. McCullough, Xuan Ye |
| Assignee: | ExxonMobil Chemical Patents Inc |
| Application Number: | US15/877,143 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,696,758
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | 24-Apr-09 | 10,696,758 | 2038-01-22 |
| Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | 15-May-13 | 10,696,758 | 2038-01-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,696,758
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 110325561 | ⤷ Start Trial |
| European Patent Office | 3583141 | ⤷ Start Trial |
| European Patent Office | 3854825 | ⤷ Start Trial |
| South Korea | 20190112293 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
